All GLP-1 class drugs carry boxed warnings about thyroid C-cell tumors observed in rodent scientific studies, however this possibility hasn't been verified in people. The Decide on cardiovascular results trial demonstrated that semaglutide really decreased significant adverse cardiovascular activiti